# Michele Senni

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michele-senni/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,146 |
| Field | Heart Failure Treatment and Management |
| h-index | 76 |
| i10-index | 256 |
| Last Known Institution | Ospedale Papa Giovanni XXIII |
| OpenAlex ID | https://openalex.org/A5060241741 |
| ORCID iD | https://orcid.org/0000-0001-5502-7882 |
| Works | 554 |

## Researcher papers

Showing 12 of 14.

- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [Congestive Heart Failure in the Community](https://scholariq.org/papers/congestive-heart-failure-in-the-community/)
- [Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era](https://scholariq.org/papers/reduction-of-hospitalizations-for-myocardial-infarction-in-italy-in-the-covid-19/)
- [Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure](https://scholariq.org/papers/angiotensin-receptor-neprilysin-inhibition-compared-with-enalapril-on-the-risk/)
- [Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes](https://scholariq.org/papers/semaglutide-in-patients-with-obesity-related-heart-failure-and-type-2-diabetes/)
- [Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure](https://scholariq.org/papers/sacubitril-valsartan-across-the-spectrum-of-ejection-fraction-in-heart-failure/)
- [Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure](https://scholariq.org/papers/renal-effects-and-associated-outcomes-during-angiotensin-neprilysin-inhibition/)
- [Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis](https://scholariq.org/papers/clinical-presentation-and-outcome-in-a-contemporary-cohort-of-patients-with/)
- [Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure](https://scholariq.org/papers/impact-of-diabetes-on-epidemiology-treatment-and-outcomes-of-patients-with-heart/)
- [Developing Therapies for Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/developing-therapies-for-heart-failure-with-preserved-ejection-fraction/)
- [Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial](https://scholariq.org/papers/patiromer-for-the-management-of-hyperkalemia-in-heart-failure-with-reduced/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Ospedale Papa Giovanni XXIII](https://scholariq.org/institutions/ospedale-papa-giovanni-xxiii/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.